Red Cedar Capital, LLC Amgen Inc Transaction History
Red Cedar Capital, LLC
- $158 Million
- Q4 2022
A detailed history of Red Cedar Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Red Cedar Capital, LLC holds 2,280 shares of AMGN stock, worth $672,121. This represents 0.38% of its overall portfolio holdings.
Number of Shares
2,280
Previous 2,280
-0.0%
Holding current value
$672,121
Previous $514,000
16.54%
% of portfolio
0.38%
Previous 0.35%
Shares
1 transactions
Others Institutions Holding AMGN
# of Institutions
3,098Shares Held
404MCall Options Held
7.75MPut Options Held
6.9M-
Vanguard Group Inc Valley Forge, PA52.4MShares$15.4 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.6 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$8.64 Billion0.39% of portfolio
-
Morgan Stanley New York, NY14.7MShares$4.33 Billion0.35% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA13.2MShares$3.89 Billion0.65% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $158B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...